Ramifenazone hydrochloride salt
CAS : 18342-39-7
Ref. 3D-FR27674
5mg | Arrêté | ||
10mg | Arrêté | ||
25mg | Arrêté | ||
50mg | Arrêté | ||
100mg | Arrêté |
Informations sur le produit
- 1,2-Dihydro-1,5-dimethyl-4-[(1-methylethyl)amino]-2-phenyl-3H-pyrazol-3-one hydrochloride4-(Isopropylamino)antipyrine hydrochloride 1-Phenyl-2,3-dimethyl-4-isopropylaminopyrazolone hydrochloride
- 1,2-Dihydro-4-(isopropylamino)-1,5-dimethyl-2-phenyl-3H-pyrazol-3-one hydrochloride
- 1,5-dimethyl-2-phenyl-4-(propan-2-ylamino)-1,2-dihydro-3H-pyrazol-3-one hydrochloride hydrate
- 3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-[(1-methylethyl)amino]-2-phenyl-, hydrochloride (1:1)
- 3H-Pyrazol-3-one, 1,2-dihydro-1,5-dimethyl-4-[(1-methylethyl)amino]-2-phenyl-, monohydrochloride
- Antipyrine, 4-(isopropylamino)-, monohydrochloride
- Isopyrine hydrochloride
- Ramifenazone hydrochloride
Ramifenazone hydrochloride salt is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits the cyclooxygenase enzyme. It is a cb2 receptor agonist and has been shown to have analgesic, antipyretic, and anti-inflammatory properties in test samples. Ramifenazone hydrochloride salt has also been demonstrated to be biocompatible with polymer surfaces and may be used as an anti-infective agent. The molecular modeling study demonstrated that the compound can form nanoparticulate compositions with various pharmacological agents. These compounds can be used for acute toxicities or protein data.